{
  "id": 20004,
  "origin_website": "Wiley",
  "title": "In Vitro Generation of Posterior Motor Neurons from Human Pluripotent Stem Cells",
  "procedures": [
    "The initial step of the differentiation protocol depends upon the high yield generation of NMP-like cells from hPSCs driven by simultaneous stimulation of the WNT and FGF signaling pathways and inhibition of BMP activity (Fig. 1A[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0001]) to limit induction of neural crest progenitors (Frith et al., 2018[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-bib-0008]). These are marked by the co-expression of TBXT and SOX2, transcriptional factors indicative of a mesodermal and neural identity, respectively. Moreover, NMP cultures exhibit expression of other posteriorly expressed genes, such as NKX1-2, CDX2 and Hox family members.\n<p>imgsrc:https://currentprotocols.onlinelibrary.wiley.com/cms/asset/1c205f42-22c4-4830-9ac3-ea08fc0086c3/cpz1244-fig-0001-m.jpg</p>\nFigure 1\nIn vitro differentiation of NMP-like cells from hPSCs. (A) Culture conditions used for induction of NMPs. (B) Representative brightfield images of NMP-like cells on day 3. (C) Immunofluorescence images showing co-expression of SOX2 and TBXT, which defines the NMP state.\nMaterials\n0.6 mg/ml vitronectin (Thermo Fisher Scientific, cat. no. A31804), stored in 200-μl aliquots at −80°C\nSterile PBS\nHuman pluripotent stem cells (hPSCs) grown to 60%-80% confluency\n5 mM UltraPure EDTA, pH 8.0 (Thermo Fisher Scientific, cat. no. 15575020) in sterile PBS, stored at 4°C\nDMEM F-12 medium with 15 mM HEPES, without l-glutamine (Sigma, cat. no. D6421)\nN2B27 medium (see recipe[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-rec-0002]), freshly prepared\nAntibodies for confirming cell identity:\n               \nAnti-SOX2 (Abcam, cat. no. ab92494, RRID AB_10585428)\nAnti-TBXT (R&D, cat. no. AF2085, RRID AB_2200235)\nMultiwell cell culture plates\n37°C/5% CO2 incubator\n15-ml conical tubes (Falcon)\nHemocytometer\nAdditional reagents and solutions for standard antibody staining protocols\nDay 0: Prepare vitronectin-coated plates 30 min before use\n1. Thaw an aliquot of 0.6 mg/ml vitronectin stock at room temperature.\nAs a general guide, 150 µl of prepared solution per cm2 should allow full coverage, which will require 1.5 µl of stock solution per cm2.",
    "The total number of wells needed will depend on the user's needs and extent of analysis. We typically employ 12-well plates and include an extra 20 wells for confirming cell identities throughout the process, as follows: 2 wells for qPCR on days 3, 8, 14, and 24; 2 wells for immunofluorescence on days 3 and 14; 4 wells for immunofluorescence on days 8 and 24.\n2. Dilute 1:100 with sterile PBS (final 6 µg/ml).\n3. Cover the entire surface of multiwell plates with vitronectin (150 µl/cm2) and incubate 1 hr at room temperature or overnight at 37°C/5% CO2.\nVitronectin should not be removed until cells are seeded.\nDay 0: Seed hPSCs\n4. Aspirate medium from hPSCs with a confluency of 60%-80%.\n5. Add enough 5 mM EDTA to cover the cells (150 µl/cm2) and incubate 5 min at 37°C/5% CO2.\n6. Aspirate EDTA and apply DMEM-F12 medium (150 µl/cm2) to lift cells as small clumps.\n7. Transfer suspended cells to a 15-ml Falcon tube and spin 4 min at 200 × g.\n8. Resuspend cell pellet in 1 ml freshly prepared N2B27 medium supplemented with 10 μM Y-27632.\nSmall molecules and recombinant proteins should be added to medium fresh each day.\n9. Count cells in a 10-μl aliquot using a hemocytometer.\n10. Aspirate vitronectin from the culture plates and add 150 µl/cm2 N2B27 medium with 10 μM Y-27632 to each well.\n11. Plate cells at a density of 60,000 cells/cm2.\n12. Rock gently to distribute the cells evenly across the wells and incubate overnight at 37°C/5% CO2.\nDay 1: Replenish medium\n13. Aspirate medium and replace with freshly prepared N2B27 medium without Y-27632.\nY-27632 should be included only for the first 24 hr of differentiation.\n14. Incubate until day 3 at 37°C/5% CO2.",
    "NMP differentiation is complete on day 3. Cells should appear as a confluent monolayer (see Fig. 1B[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0001]).\nDay 3: Assess differentiation\n15. On day 3, confirm the NMP cell type by antibody staining.\nSuccessfully differentiated NMPs should co-express TBXT and SOX2 (Fig. 1C[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0001]). Efficient induction of CDX2 and other genes denoting a posterior axial identity (as reviewed by Wymeersch et al., 2021[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-bib-0024]) can also be assessed by immunostaining/qPCR.",
    "This protocol encompasses the directed differentiation of human NMPs to a posterior ventral spinal cord identity. It relies on combined BMP and TGF-β inhibition and supplementation by retinoic acid and SHH agonist signals (Figs. 2A[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0002], 3A[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0003]) to first promote generation of HOXC9+/SOX1+/PAX6+ posterior neurectoderm cells and subsequently induce differentiation of ventral spinal cord progenitors.\n<p>imgsrc:https://currentprotocols.onlinelibrary.wiley.com/cms/asset/9cf9bf37-ac19-45d9-b041-840afceaab13/cpz1244-fig-0002-m.jpg</p>\nFigure 2\nIn vitro differentiation of posterior neurectoderm. (A) Culture conditions used for induction of posterior neurectoderm. (B) Representative images of cells after successful posterior neurectoderm differentiation. (C) Immunofluorescence images showing expression of SOX2, PAX6, SOX1, and HOXC9, plus low expression of OLIG2 and the absence of TBXT. Scale bars: 100 µm (D) qPCR analysis showing induction of neural progenitor and posterior axial identity markers. Error bars represent s.d. (n = 3).\n<p>imgsrc:https://currentprotocols.onlinelibrary.wiley.com/cms/asset/13923f92-8555-4e21-81e9-081fb45add1b/cpz1244-fig-0003-m.jpg</p>\nFigure 3\nIn vitro differentiation of posterior ventral spinal cord progenitors. (A) Culture conditions used for induction of posterior ventral spinal cord progenitors. LA, l-ascorbic acid; RA, retinoic acid. (B) Representative images showing successfully differentiated cells on day 14. (C) Immunofluorescence images showing HOXC9 and OLIG2 expression in day 14 ventral spinal cord progenitors. Scale bars: 100 µm. (D) qPCR analysis showing expression of ventral spinal cord progenitor and posterior axial identity markers at day 14. Error bars represent s.d. (n = 3).\nMaterials\nNMPs (see Basic Protocol 1[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-prot-0001])\nGeltrex LDEV-Free Reduced Growth Factor Basement Membrane Matrix (Thermo Fisher Scientific, cat. no. A1413201), stored in 100-μl aliquots at −80°C\nDMEM F-12 medium with 15 mM HEPES, without l-glutamine (Sigma, cat. no. D6421)\nAccutase (Sigma, cat. no. A6964)\nPosterior neurectoderm induction medium (see recipe[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-rec-0003]), freshly prepared\nPosterior ventral spinal cord progenitor induction medium (see recipe[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-rec-0004]), freshly prepared\nAntibodies for confirming cell identity:\n               \nAnti-SOX2 (Abcam, cat. no. ab92494, RRID AB_10585428)\nAnti-TBXT (R&D, cat. no. AF2085, RRID AB_2200235)\nAnti-PAX6 (Biolegend, cat. no. 901302, RRID AB_2749901)",
    "Anti-SOX1 (R&D, cat. no. AF3369, RRID AB_2239879)\nAnti-HOXC9 (Abcam, cat. no. ab50839, RRID AB_880494)\nAnti-OLIG2 (R&D, cat. no. AF2418, RRID AB_2157554)\nPrimers for confirming cell identity (see Table 1[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-tbl-0001])\nMultiwell cell culture plates\n37°C/5% CO2 incubator\n15-ml conical tubes (Falcon)\nHemocytometer\nAdditional reagents and solutions for standard antibody staining and qPCR protocols\nTable 1.\n                Primers for Characterizing Cell Identity by qPCR\ntable:\n﻿Primer,Forward,Reverse,Reverse.1\nFor posterior neuroectoderm:,For posterior neuroectoderm:,For posterior neuroectoderm:,For posterior neuroectoderm:\nSOX2,ttgctgcctctttaagactagga,Taagcctggggctcaaact,Taagcctggggctcaaact\nSOX1,gaagcccagatggaaatacg,ggacaaggaagggtgttgag,ggacaaggaagggtgttgag\nPAX6,gcacacacacattaacacacttg,ggtgtgtgagagcaattctcag,ggtgtgtgagagcaattctcag\nCDX2,atcaccatccggaggaaag,tgcggttctgaaaccagatt,tgcggttctgaaaccagatt\nHOXC6,tgaattcctacttcactaacccttc,atcataggcggtggaattga,atcataggcggtggaattga\nHOXC8,tcccagcctcatgtttcc,tgataccggctgtaagtttgc,tgataccggctgtaagtttgc\nHOXD8,cccttgtaatcgcctgaaat,ctactgaaaataacggaacacagc,ctactgaaaataacggaacacagc\nHOXA9,ccccatcgatcccaataa,caccgctttttccgagtg,caccgctttttccgagtg\nHOXC9,tcctagcgtccaggtttcc,gctacagtccggcaccaa,gctacagtccggcaccaa\nFor ventral spinal cord progenitors:,For ventral spinal cord progenitors:,For ventral spinal cord progenitors:,For ventral spinal cord progenitors:\nNKX6.1,gagatgaagaccccgctgta,gacgacgacgaggacgag,gacgacgacgaggacgag\nNKX6.2,agcacaaaccctcgaacttg,cccggattctgcaaaaatag,cccggattctgcaaaaatag\nOLIG2,agctcctcaaatcgcatcc,atagtcgtcgcagctttcg,atagtcgtcgcagctttcg\nLHX3,gttcaggaggggcaggac,ctcccgtagaggccattg,ctcccgtagaggccattg\nHOXC6,tgaattcctacttcactaacccttc,atcataggcggtggaattga,atcataggcggtggaattga\nHOXC8,tcccagcctcatgtttcc,tgataccggctgtaagtttgc,tgataccggctgtaagtttgc\nHOXD8,cccttgtaatcgcctgaaat,ctactgaaaataacggaacacagc,ctactgaaaataacggaacacagc\nHOXC9,tcctagcgtccaggtttcc,gctacagtccggcaccaa,gctacagtccggcaccaa\nFor posterior motor neurons:,For posterior motor neurons:,For posterior motor neurons:,For posterior motor neurons:\nISLET1,aaacaggagctccagcaaaa,aaacaggagctccagcaaaa,aaaggactctttcagccaagg\nMNX1,ttacctgacttatgaaacttgaaacc,ttacctgacttatgaaacttgaaacc,cccagagacgtaagcataaacc\nCDX2,atcaccatccggaggaaag,atcaccatccggaggaaag,tgcggttctgaaaccagatt\nHOXC6,tgaattcctacttcactaacccttc,tgaattcctacttcactaacccttc,atcataggcggtggaattga\nHOXC8,tcccagcctcatgtttcc,tcccagcctcatgtttcc,tgataccggctgtaagtttgc\nHOXD8,cccttgtaatcgcctgaaat,cccttgtaatcgcctgaaat,ctactgaaaataacggaacacagc\nHOXC9,tcctagcgtccaggtttcc,tcctagcgtccaggtttcc,gctacagtccggcaccaa\nDay 3: Prepare Geltrex-coated plates\n1. Thaw an aliquot of Geltrex by resuspending 1:100 with cold (4°C) sterile DMEM-F12 medium.\nThawing quickly with cold medium is important to prevent crystallization.\n2. Add Geltrex to cover the entire surface of the multiwell culture plates (150 µl/cm2) and incubate 1 hr at 37°C/5% CO2.\nGeltrex should not be removed until cells are seeded.\nDays 3-7: Perform posterior neuroectoderm differentiation\n3. Aspirate medium from NMPs and add Accutase to cover the cells (150 µl/cm2). Incubate 5 min at 37°C/5% CO2.\n4. Add excess DMEM-F12 (at least 2 vol. relative to Accutase) and triturate gently to create a single-cell suspension.\n5. Transfer cell suspension to a 15-ml Falcon tube and centrifuge 4 min at 200 × g.\n6. Resuspend cell pellet in 1 ml of freshly prepared posterior neurectoderm induction medium supplemented with 10 μM Y-27632.\nSmall molecules and recombinant proteins should be added to medium fresh each day.\n7. Count cells in a 10-μl aliquot using a hemocytometer.",
    "8. Aspirate Geltrex from the culture plates and add 150 µl/cm2 of posterior neurectoderm induction medium with 10 μM Y-27632 to each well.\n9. Plate cells at a density of 60,000 cells/cm2.\n10. Rock gently to distribute the cells evenly across the wells and incubate overnight at 37°C/5% CO2.\n11. On days 4 and 6, aspirate medium and replace with fresh medium without Y-27632 (150 µl/cm2).\nY-27632 is included only on days 3 and 7 when cells are replated.\nDays 7-14: Perform posterior ventral spinal cord progenitor differentiation\n12. On day 7, repeat steps 1-11 to replate cells at a density of 80,000 cells/cm2.\nOn day 7, before replating, successfully differentiated cells should appear as a confluent monolayer with clusters/clumps beginning to form (Fig. 2B[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0002]).\n13. On day 8, aspirate medium and replace with fresh medium without Y-27632 (150 µl/cm2).\n14. Also on day 8, confirm posterior neuroectoderm cell type by antibody staining and qPCR.\nSuccessful generation of a posterior neurectoderm identity, at day 8, can be identified by co-expression of the neural progenitor markers SOX1 and PAX6, together with expression of CDX2 and posterior HOX PG(6-9), indicating a posterior brachial/thoracic axial identity (Fig. 2C[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0002],D[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0002]). Furthermore, maintenance of expression of SOX2 (a neural progenitor marker) and loss of TBXT (a marker of mesodermal progenitors) indicates efficient neural conversion of NMPs.\n15. On day 9, aspirate medium and replace with fresh medium without Y-27632 (150 µl/cm2).\n16. On day 10, aspirate medium and switch to fresh posterior ventral spinal cord progenitor induction medium (150 µl/cm2).\n17. On day 12, aspirate medium and replace with fresh medium posterior ventral spinal cord progenitor induction medium (150 µl/cm2).",
    "Posterior ventral spinal cord progenitor differentiation is complete on day 14. Cells should display clear signs of forming spiky projections at the edges of colonies (Fig. 3B[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0003]).\nDay 14: Assess differentiation\n18. On day 14, confirm the posterior ventral spinal cord progenitor cell type by antibody staining and qPCR.\nExpression of defined ventral/motor neuron progenitor markers NKX6.1, NKX6.2, OLIG2, and LHX3, by day 14 of differentiation demonstrates efficient induction of ventral spinal cord progenitors (Fig. 3C[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0003],D[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0003]). Similarly, continued expression of posterior HOX PG(6-9) genes indicates a robust posterior identity.",
    "The final step of the procedure allows for promotion of a post-mitotic posterior motor neuron identity. Supplementation with the γ-secretase inhibitor DAPT promotes exit from a progenitor state, and the presence of neurotrophins promotes neuronal survival and axonal outgrowth (Fig. 4A[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0004]).\n<p>imgsrc:https://currentprotocols.onlinelibrary.wiley.com/cms/asset/0c25fae6-2471-4a03-9327-4c5455ae29bb/cpz1244-fig-0004-m.jpg</p>\nFigure 4\nIn vitro differentiation of posterior MNs. (A) Culture conditions used for induction of posterior MNs. LA, l-ascorbic acid; RA, retinoic acid. (B) Representative images showing cells on day 24 after successful posterior MN differentiation. (C) Immunofluorescence images showing expression of the MN-specific markers ISLET1, neurofilament, MNX1, and ChAT as well as the preganglionic motor column marker nNOS. Scale bars: 100 µm (D) qPCR analysis showing induction of MN and posterior axial identity markers. Error bars represent s.d. (n = 3).\nMaterials\nGeltrex LDEV-Free Reduced Growth Factor Basement Membrane Matrix (Thermo Fisher Scientific, cat. no. A1413201), stored in 100-μl aliquots at −80°C\nDMEM F-12 medium with 15 mM HEPES, without l-glutamine (Sigma, cat. no. D6421)\nPosterior ventral spinal cord progenitors (see Basic Protocol 2[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-prot-0002])\nAccutase (Sigma, cat. no. A6964)\nMotor neuron maturation medium (see recipe[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-rec-0001]), freshly prepared\nAntibodies for confirming cell identity:\n               \nAnti-ISELT1 (R&D, cat. no. AF1837, RRID AB_2126324)\nAnti-ISLET1/2 (DSHB, cat. no. 39.4D5, RRID AB_2314683)\nAnti-neurofilament (Abcam, cat. no. ab8135, RRID AB_306298)\nAnti-nNOS (Thermo Fisher Scientific, cat. no. 37-2800, RRID AB_2533308)\nAnti-MNX1 (DSHB, cat. no. 81.5C10, RRID AB_2145209)\nAnti-cholinergic acetyltransferase (Abcam, cat. no. ab144P, RRID AB_90661)\nPrimers for confirming cell identity (see Table 1[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-tbl-0001])\nMultiwell cell culture plates\n37°C/5% CO2 incubator\n15-ml conical tubes (Falcon)\nHemocytometer\nAdditional reagents and equipment for standard antibody staining, qPCR, and patch-clamp recording protocols\nDay 14: Perform posterior motor neuron differentiation\n1. On day 14, prepare fresh Geltrex-coated plates as described (see Basic Protocol 2[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-prot-0002], steps 1-2).",
    "2. Aspirate medium from ventral cord progenitor cells and add Accutase (150 µl/cm2) to cover the cells. Incubate 5 min at 37°C/5% CO2.\n3. Add excess DMEM-F12 (at least 2 vol. relative to Accutase) and triturate gently to create a single-cell suspension.\n4. Transfer cell suspension to a 15-ml Falcon tube and centrifuge 4 min at 200 × g.\n5. Resuspend cell pellet in 1 ml of freshly prepared motor neuron maturation medium supplemented with 10 μM Y-27632.\nSmall molecules and recombinant proteins should be added to medium fresh each day.\n6. Count cells in a 10-μl aliquot using a hemocytometer.\n7. Aspirate Geltrex from the culture plates and add 150 µl/cm2 of motor neuron maturation medium with 10 μM Y-27632 to each well.\n8. Plate cells at a density of 100,000 cells/cm2.\n9. Rock gently to distribute the cells evenly across the wells and incubate 48 hr at 37°C/5% CO2.\n10. On days 16, 18, 20, and 22, aspirate medium and replace with fresh motor neuron maturation medium without Y-27632 (150 µl/cm2).\nY-27632 is included only on day 14 when cells are replated.\nAxonal projections should be clearly visible on day 16.\nDay 24: Assess differentiation\n11. On day 24, confirm posterior motor neuron differentiation by antibody staining, qPCR, and electrophysiology.",
    "On day 24, posterior motor neuron differentiation should be complete. Cells should display clear clusters of neuronal cell bodies with fasciculated axonal projections to adjacent clusters (Fig. 4A[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0004]). A mature motor neuron identity can be confirmed by expression of ISLET1, MNX1, cholinergic acetyltransferase (ChAT), and neurofilament (Fig. 4C[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0004],D[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0004]). Expression of HOX PG(6-9) indicates a posterior motor neuron identity, while expression of nNOS suggests a high yield of thoracic-specific preganglionic motor column character (Fig. 4C[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0004],D[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-fig-0004]). Electrophysiological functionality, displayed through whole-current patch-clamp recordings, can also be used to demonstrate the functional maturity of the derived motor neurons (Wind et al., 2021[href=https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.244#cpz1244-bib-0022])."
  ],
  "subjectAreas": [
    "Stem Cell Biology"
  ],
  "bigAreas": [
    "Biomedical & Clinical Research"
  ]
}